The MicroByte Series -Staphylococcus epidermidis: A Double-Edged Sword

Sep 17, 2025

•

4 min read

•

First identified in 1884, Staphylococcus epidermidis is a versatile Gram-positive bacterium capable of acting as a complex double-edged sword in human health. Driven by an advanced arsenal of anchoring proteins and ceramide-boosting enzymes, it effortlessly colonizes epithelial surfaces, spreading rapidly through dry, sebaceous, and moist mucous membranes. Impacts range from beneficial skin barrier hydration and childhood immune system training to hazardous hospital-acquired infections via implanted medical devices and intravenous lines. Accurate identification leverages classic laboratory profiling and modern clinical culture analysis. While optimization typically requires targeted probiotic therapy for skin-protective strains, active infection management relies heavily on precise diagnostic verification and prompt antibiotic treatment.

History and naming

Staphylococcus epidermidis, whose name comes from ‘staphyl ’, meaning its grape-bunch-like appearance under a microscope, ‘coccus ’, which indicates the round shape of the cells, and ‘epidermidis ’, from its strong association with the skin. However, this bacterium went by several names prior. In 1884, Friedrich Rosenbach differentiated it from S. aureus, naming it Staphylococcus albus, due to its white appearance. Later, when bacteria were split according to their colony colours, Winslow and Winslow proposed its renaming to Albococcus epidermidis, acknowledging its role in the skin. It was later grouped back with the Staphylococcus genus, and it remains S. epidermidis to this date.

Coccus- A scientific term used to describe any bacterium that has a round, spherical, or berry-like shape.

Genus- A biological classification rank that groups closely related species together; it forms the very first part of an organism's formal scientific name.

Habitat

S. epidermidis, as its name suggests, can live in all types of skin sites, be it dry, sebaceous, or oily, but prefers moist sites. In terms of body sites, it is found in the armpit, nostrils, and face, as it is adapted to also thrive in mucous membranes.

Sebaceous- Relating to the oil-producing glands in the skin that secrete a fatty, lubricating substance called sebum.

Mucous membranes- The moist, protective inner layers of tissue that line body cavities exposed to the outside world, such as the nose, mouth, and lungs.

Health Benefits

S. epidermidis has several useful properties that allow it to inhabit the skin and be part of the skin microbiome. It has anchoring proteins, which allow it to attach to the skin’s surface, where it plays important roles throughout a person’s lifetime- it is believed we first encounter this microbe in the womb. During childhood, it ‘trains’ the immune system. This ‘training’ allows the immune system to recognise the normal microbiota and only react against harmful microbes that can cause infection and disease. It can also produce enzymes to increase ceramide levels in the skin, which help maintain its hydration. Interestingly, it also competes with Staphylococcus aureus, known to be associated with severe infections and skin conditions, by secreting antimicrobial compounds or by recruiting immune cells. S. epidermidis also plays a similar immune-modulating role in the nasal microbiome and may be involved in fighting off respiratory infections.

Immune system- The body's complex internal network of organs, tissues, and cells that constantly work together to protect against infections and diseases.

Ceramide levels- The amount of specialized fat molecules (lipids) present in the skin that are crucial for locking in moisture and keeping the skin healthy.

Antimicrobial compounds- Protective substances produced by cells or friendly microbes that directly weaken, stop the growth of, or destroy competing, harmful germs.

Immune cells- The body's specialized frontline defense forces (white blood cells) that constantly patrol tissues to identify, attack, and eliminate dangerous invaders.

Applications of S. epidermidis

The positive roles played by S. epidermidis in skin health are beginning to be harnessed through the development of probiotics. An exploratory study showed that isolated S. epidermidis from a human’s own facial skin, when re-applied, improved skin barrier integrity and hydration. It has also been proposed that the introduction of this commensal into the nostril during respiratory infection could help in faster recovery due to its ability to compete with pathogens and harness the immune system. Certain strains of S. epidermidis have also been shown to reduce S. aureus when applied to patients with atopic dermatitis- a condition typically known to be made worse by this pathogen. Further research is needed to identify strains of S. epidermidis that can exert positive effects while posing minimal risk.

Skin barrier integrity- The overall strength, wholeness, and functional health of the skin’s outermost layer, which acts as a shield to keep hydration in and harmful elements out.

Commensal- A type of microbe that naturally lives on or inside a host organism, benefiting from the environment without causing any harm under normal conditions.

Pathogens- Any disease-causing microscopic organisms, such as dangerous bacteria, viruses, fungi, or parasites.

Strains- Specific genetic sub-types or unique variants within a single bacterial species, with each strain often displaying its own distinct behavior or traits.

Risks

Despite its several interesting and beneficial properties, and being low-virulent, S. epidermidis is also known to cause infection, being one of the leading causes of hospital-acquired infections. It commonly enters the body through the process of implanting prosthetics and medical devices, or IV lines and injections, due to its presence on the skin. These infections must be identified and treated promptly through appropriate culture analysis and antibiotic treatment.

Low-virulent- Having a low capacity or weak ability to cause severe disease, damage, or harm to a host organism.

Culture analysis- A laboratory test where microbes from a swab or sample are grown under controlled conditions so scientists can precisely identify and study them.

Antibiotic treatment- The medical use of targeted drugs specifically designed to destroy or slow down the growth of bacteria during an active infection.

Microbe Profile

Gram nature: Positive

Shape: Cocci

Spore formation: No

Biofilm formation: Yes

Coagulase enzyme: Negative

Oxygen requirement: Facultative anaerobe- can grow in low or high oxygen

Optimal temperature: 30–37°C

Temperature range: 6.5–46°C

Optimal pH: 5-7

Heat resistance: Some food-isolated strains can even survive at 80°C

Taxonomic classification

Domain: Bacteria

Phylum: Bacillota

Class: Bacilli

Order: Bacillales

Family: Staphylococcaceae

Genus: Staphylococcus

Species: Staphylococcus epidermidis

-Antara Arvind

Reference

Licitra G. (2013). Etymologia: Staphylococcus. Emerging Infectious Diseases, 19(9), 1553. https://doi.org/10.3201/eid1909.ET1909

Otto M. (2009). Staphylococcus epidermidis--the 'accidental' pathogen. Nature reviews. Microbiology, 7(8), 555–567. https://doi.org/10.1038/nrmicro2182

Severn, M. M., & Horswill, A. R. (2023). Staphylococcus epidermidis and its dual lifestyle in skin health and infection. Nature reviews. Microbiology, 21(2), 97–111. https://doi.org/10.1038/s41579-022-00780-3

Kim, H.J., Jo, A., Jeon, Y.J. et al (2019). Nasal commensal Staphylococcus epidermidis enhances interferon-λ-dependent immunity against influenza virus. Microbiome 7, 80. https://doi.org/10.1186/s40168-019-0691-9

Nodake, Y., Matsumoto, S., Miura, R., Honda, H., Ishibashi, G., Matsumoto, S., Dekio, I., & Sakakibara, R. (2015). Pilot study on novel skin care method by augmentation with Staphylococcus epidermidis, an autologous skin microbe--A blinded randomized clinical trial. Journal of dermatological science, 79(2), 119–126. https://doi.org/10.1016/j.jdermsci.2015.05.001

Ortega-Peña, S., Rodríguez-Martínez, S., Cancino-Diaz, M. E., & Cancino-Diaz, J. C. (2022). Staphylococcus epidermidis Controls Opportunistic Pathogens in the Nose, Could It Help to Regulate SARS-CoV-2 (COVID-19) Infection? Life, 12(3), 341. https://doi.org/10.3390/life12030341

Teruaki Nakatsuji et al. (2017), Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis.Sci. Transl. Med.9, eaah4680.DOI:10.1126/scitranslmed.aah4680

Lee E, Anjum F. Staphylococcus epidermidis Infection. [Updated 2023 Apr 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK563240/

Chiara Montanari, Diana I. Serrazanetti, et al (2015), New insights in thermal resistance of staphylococcal strains belonging to the species Staphylococcus epidermidis, Staphylococcus lugdunensis and Staphylococcus aureus, Food Control, Volume 50, Pages 605-612, ISSN 0956-7135, https://doi.org/10.1016/j.foodcont.2014.09.039.

Pedroza-Dávila, U., Uribe-Alvarez, C., Morales-García, L., Espinoza-Simón, E., Méndez-Romero, O., Muhlia-Almazán, A., Chiquete-Félix, N., & Uribe-Carvajal, S. (2020). Metabolism, ATP production and biofilm generation by Staphylococcus epidermidis in either respiratory or fermentative conditions. AMB Express, 10(1), 31. https://doi.org/10.1186/s13568-020-00966-z.

Skovdal, S. M., Jørgensen, N. P., & Meyer, R. L. (2022). JMM Profile: Staphylococcus epidermidis. Journal of Medical Microbiology, 71(10). https://doi.org/10.1099/jmm.0.001597.

STAPHYLOCOCCUS EPIDERMIDIS

PROBIOTICS

Frequently Asked Questions

What historical names did this bacterium hold before its current classification?

In 1884, Friedrich Rosenbach named it Staphylococcus albus due to its white appearance under laboratory cultivation. It was later temporarily renamed Albococcus epidermidis before scientists permanently returned it to the Staphylococcus genus.

How does Staphylococcus epidermidis support a child's early immune development?

During childhood, this commensal organism actively trains the human immune system to recognize and accept friendly microbiota. This critical calibration prevents the body from overreacting, ensuring it only launches defenses against dangerous pathogens.

Through what mechanism does this bacterium improve skin hydration and strength?

It produces specific enzymes that boost skin ceramide levels, which are fat molecules essential for locking in vital moisture. Topical application of this microbe has been clinically shown to reinforce skin barrier integrity and enhance hydration.

In what ways does this microbe actively counter the harmful Staphylococcus aureus?

It successfully suppresses the dangerous pathogen by directly secreting protective antimicrobial compounds onto the skin surface. Additionally, it can recruit host immune cells to clear out S. aureus overgrowth in conditions like atopic dermatitis.

Why is this low-virulent bacterium a leading cause of hospital infections?

Due to its permanent presence on human skin, it easily hitches a ride inside the body during invasive medical procedures. It typically gains entry through clinical access points like intravenous lines, routine injections, or implanted prosthetic devices.

BugSpeaks®

BugSpeaks®, developed by Leucine Rich Bio Pvt Ltd, South Asia’s first microbiome company, is headquartered in Bengaluru, India. Since 2014, the company has pioneered advanced analytics to analyze complex genomics data. Collaborating with leading research institutes globally, Leucine Rich Bio has leveraged its expertise to create BugSpeaks®, South Asia’s first gut microbiome test.

Visit Site